Gateway Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Gateway Wealth Partners's BMY Position: Q1 2026 in Review
Gateway Wealth Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 8,986 shares worth $545K. The stake represents 0.02% of the portfolio and ranks #553 among its holdings. This is a return to the name: Gateway Wealth Partners previously reported a position in BMY as recently as Q1 2024.
Gateway Wealth Partners first reported a position in BMY in Q2 2023 and has held it in 5 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Gateway Wealth Partners held 8,986 shares of Bristol-Myers Squibb worth $545K as of Q1 2026.
- Bristol-Myers Squibb was a new Gateway Wealth Partners position in Q1 2026.
- Bristol-Myers Squibb made up 0.02% of Gateway Wealth Partners's portfolio in Q1 2026, its #553 holding.
- Gateway Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 5 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Gateway Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.